Status:
UNKNOWN
A Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus Golytely
Lead Sponsor:
Oregon Health and Science University
Conditions:
Colonoscopy
Eligibility:
All Genders
50-90 years
Phase:
PHASE4
Brief Summary
Prior to colonoscopies, the colon is cleansed using a laxative. Golytely is approved by the FDA for this purpose. Another laxative, called MiraLax, is approved by the FDA to relieve constipation, but ...
Eligibility Criteria
Inclusion
- average risk screening for colon cancer
Exclusion
- subjects with a history of constipation
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
432 Patients enrolled
Trial Details
Trial ID
NCT00889655
Start Date
May 1 2009
End Date
May 1 2010
Last Update
April 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Sciences University
Portland, Oregon, United States, 97239